R3 Stem Cell

• Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions

  Phase 1, Not yet recruiting, 5,000 people, Apr 2, 2019

Sources: clinicaltrials.gov